Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

BerGenBio - Filing #2581090

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
Disclosure of effect of changes in foreign exchange rates [text block]
Disclosure of information when currency is not exchangeable into another currency [text block]
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]
Disclosure of summarised financial information about foreign operation [text block]
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets
43,000 NOK
1,191,000 NOK
Current assets
166,663,000 NOK
449,045,000 NOK
Non-current liabilities
275,000 NOK
942,000 NOK
Current liabilities
77,933,000 NOK
64,868,000 NOK
Revenue
389,000 NOK
774,000 NOK
Profit (loss)
302,122,000 NOK
302,122,000 NOK
309,364,000 NOK
309,364,000 NOK
Comprehensive income
0 NOK
302,606,000 NOK
302,606,000 NOK
0 NOK
309,476,000 NOK
0 NOK
0 NOK
309,476,000 NOK

Talk to a Data Expert

Have a question? We'll get back to you promptly.